Essentially, PSME3 serves as an oncogene, as is indicated by the existing studies, and promotes tumor apoptosis resistance, growth, and metastasis by modulating epithelial–mesenchymal transition, stem cell characteristics, and glycolysis in a Myc6-, Hippo-, or NF-kB13-associated manner. The gene discussed is PSME3; the disease is neoplasm.